Tudor Investment Corp
ACOR

Tudor Investment Corp’s Acorda Therapeutics ACOR Stock Holding History

Tudor Investment Corp’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-559
Closed -$193K – 1437
2019
Q3 		$193K Buy
+559
New +$304K 0.01% 963
2019
Q2 		– Sell
-129
Closed -$206K – 1403
2019
Q1 		$206K Sell
129
-449
-78% -$809K 0.01% 996
2018
Q4 		$1.08M Buy
+578
New +$1.26M 0.02% 357
2018
Q3 		– Sell
-63
Closed -$217K – 1318
2018
Q2 		$217K Buy
+63
New +$193K 0.01% 903
2018
Q1 		– Sell
-141
Closed -$362K – 1314
2017
Q4 		$362K Buy
+141
New +$401K 0.01% 737
2017
Q2 		– Sell
-103
Closed -$260K – 1453
2017
Q1 		$260K Sell
103
-84
-45% -$242K 0.01% 1086
2016
Q4 		$421K Buy
+187
New +$445K 0.01% 812
2016
Q3 		– Sell
-113
Closed -$345K – 1803
2016
Q2 		$345K Sell
113
-92
-45% -$299K 0.01% 1078
2016
Q1 		$651K Buy
+205
New +$851K 0.02% 781
2015
Q2 		– Sell
-118
Closed -$473K – 1726
2015
Q1 		$473K Buy
+118
New +$540K 0.02% 765
2014
Q1 		– Sell
-142
Closed -$496K – 1449
2013
Q4 		$496K Buy
142
+78
+122% +$304K 0.02% 561
2013
Q3 		$263K Buy
64
+2
+3% +$8.62K 0.01% 645
2013
Q2 		$244K Buy
+62
New +$255K 0.02% 651

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Tudor Investment Corp's ACOR Position: Q4 2019 in Review

Tudor Investment Corp sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 559 shares — an estimated $193K sold.

Tudor Investment Corp first reported a position in ACOR in Q2 2013 and held it in 13 quarters. The position peaked at $1.08M in Q4 2018. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Tudor Investment Corp reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Tudor Investment Corp sold 559 Acorda Therapeutics shares in Q4 2019, an estimated $193K.
  • Tudor Investment Corp first reported a position in Acorda Therapeutics in Q2 2013 and held it in 13 quarters.
  • Tudor Investment Corp's Acorda Therapeutics position peaked at $1.08M in Q4 2018.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Tudor Investment Corp's 13F filing for Q4 2019, filed 14 Feb 2020.